Synthesis and antitumor activity of an inhibitor of fatty acid synthase.

PubWeight™: 2.93‹?› | Rank: Top 1%

🔗 View Article (PMC 16260)

Published in Proc Natl Acad Sci U S A on March 28, 2000

Authors

F P Kuhajda1, E S Pizer, J N Li, N S Mani, G L Frehywot, C A Townsend

Author Affiliations

1: Department of Pathology, The Johns Hopkins University School of Medicine, 4940 Eastern Avenue, Baltimore, MD 21224, USA. fkuhajda@jhmi.edu

Articles citing this

(truncated to the top 100)

Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell (2010) 5.47

AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol (2006) 3.11

Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst (2009) 2.53

Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med (2014) 2.15

Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol (2010) 2.00

The metabolic serine hydrolases and their functions in mammalian physiology and disease. Chem Rev (2011) 1.89

Hypothalamic malonyl-CoA as a mediator of feeding behavior. Proc Natl Acad Sci U S A (2003) 1.82

C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity. Proc Natl Acad Sci U S A (2002) 1.82

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proc Natl Acad Sci U S A (2004) 1.77

Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke (2007) 1.67

Quantitation of fatty acyl-coenzyme As in mammalian cells by liquid chromatography-electrospray ionization tandem mass spectrometry. J Lipid Res (2008) 1.57

Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Dis Model Mech (2013) 1.55

AMPK in the brain: its roles in energy balance and neuroprotection. J Neurochem (2009) 1.55

Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production. Hepatology (2008) 1.52

Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids. Prog Lipid Res (2013) 1.46

Dengue virus infection perturbs lipid homeostasis in infected mosquito cells. PLoS Pathog (2012) 1.45

PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis. Cancer Res (2011) 1.43

Recent advances in the chemistry and biology of naturally occurring antibiotics. Angew Chem Int Ed Engl (2009) 1.39

Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. Int J Biochem Mol Biol (2010) 1.38

Histological evaluation of AMPK signalling in primary breast cancer. BMC Cancer (2009) 1.38

Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. J Clin Oncol (2010) 1.37

The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer. Cancer Cell (2011) 1.37

Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes. Proc Natl Acad Sci U S A (2010) 1.35

Fatty acid biosynthesis as a target for novel antibacterials. Curr Opin Investig Drugs (2004) 1.33

Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells. Breast Cancer Res (2010) 1.32

Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma. Proc Natl Acad Sci U S A (2012) 1.32

Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer. Lab Invest (2008) 1.30

SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids. PLoS One (2012) 1.29

Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle. Proc Natl Acad Sci U S A (2005) 1.25

HO-3867, a synthetic compound, inhibits the migration and invasion of ovarian carcinoma cells through downregulation of fatty acid synthase and focal adhesion kinase. Mol Cancer Res (2010) 1.16

AccD6, a member of the Fas II locus, is a functional carboxyltransferase subunit of the acyl-coenzyme A carboxylase in Mycobacterium tuberculosis. J Bacteriol (2006) 1.13

Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation. Mol Cancer Ther (2009) 1.12

Targeting SREBP-1-driven lipid metabolism to treat cancer. Curr Pharm Des (2014) 1.11

Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen. BMC Clin Pathol (2014) 1.09

Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine. Mol Cancer Ther (2008) 1.08

Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression. J Virol (2004) 1.08

The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells. Cell Cycle (2012) 1.04

Tumor suppressor p53 and its mutants in cancer metabolism. Cancer Lett (2013) 1.04

Fatty acid oxidation and meiotic resumption in mouse oocytes. Mol Reprod Dev (2009) 1.03

The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer. Semin Cell Dev Biol (2012) 1.02

Blood and tissue biomarkers in prostate cancer: state of the art. Urol Clin North Am (2010) 1.02

Stra13/DEC1 and DEC2 inhibit sterol regulatory element binding protein-1c in a hypoxia-inducible factor-dependent mechanism. Nucleic Acids Res (2008) 1.01

Lipids and prostate cancer. Prostaglandins Other Lipid Mediat (2012) 1.01

Adipocytes: impact on tumor growth and potential sites for therapeutic intervention. Pharmacol Ther (2013) 1.00

Inhibition of the fungal fatty acid synthase type I multienzyme complex. Proc Natl Acad Sci U S A (2008) 0.97

The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells. Cancer Invest (2008) 0.96

ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate turnover and subcellular localization. Elife (2015) 0.96

Characterization of the inactivation of rat fatty acid synthase by C75: inhibition of partial reactions and protection by substrates. Biochem J (2005) 0.95

The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer. Oncotarget (2014) 0.95

Hepatitis C virus replication is modulated by the interaction of nonstructural protein NS5B and fatty acid synthase. J Virol (2013) 0.95

Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells. Oncotarget (2015) 0.94

Fatty acid synthase: a novel target for antiglioma therapy. Br J Cancer (2006) 0.94

Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer. BMC Cancer (2012) 0.93

Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype. Br J Cancer (2010) 0.93

Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer. World J Gastroenterol (2014) 0.91

A missense mutation in the fabB (beta-ketoacyl-acyl carrier protein synthase I) gene confers tiolactomycin resistance to Escherichia coli. Antimicrob Agents Chemother (2002) 0.91

1,2-dithiole-3-ones as potent inhibitors of the bacterial 3-ketoacyl acyl carrier protein synthase III (FabH). Antimicrob Agents Chemother (2004) 0.91

Hypothalamic malonyl-coenzyme A and the control of energy balance. Mol Endocrinol (2008) 0.90

Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity. J Lipid Res (2010) 0.90

Diverse mechanisms of growth inhibition by luteolin, resveratrol, and quercetin in MIA PaCa-2 cells: a comparative glucose tracer study with the fatty acid synthase inhibitor C75. Metabolomics (2011) 0.90

The LeFE algorithm: embracing the complexity of gene expression in the interpretation of microarray data. Genome Biol (2007) 0.89

p63 promotes cell survival through fatty acid synthase. PLoS One (2009) 0.89

Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways. Oncotarget (2015) 0.89

Structure of the human beta-ketoacyl [ACP] synthase from the mitochondrial type II fatty acid synthase. Protein Sci (2007) 0.87

Loss of IKKbeta activity increases p53 stability and p21 expression leading to cell cycle arrest and apoptosis. J Cell Mol Med (2009) 0.87

Targeting FASN in Breast Cancer and the Discovery of Promising Inhibitors from Natural Products Derived from Traditional Chinese Medicine. Evid Based Complement Alternat Med (2014) 0.86

Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells. J Biol Chem (2012) 0.86

Fatty acid synthase as a novel target for meningioma therapy. Neuro Oncol (2010) 0.86

Retracted Fatty acid synthase is a novel therapeutic target in multiple myeloma. Br J Haematol (2008) 0.85

Saturated fatty acids modulate cell response to DNA damage: implication for their role in tumorigenesis. PLoS One (2008) 0.85

Large-scale analysis of HLA peptides presented by HLA-Cw4. Immunogenetics (2003) 0.84

Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93. Am J Pathol (2009) 0.84

Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death. Mol Cancer Ther (2008) 0.84

Chronic inflammation aggravates metabolic disorders of hepatic fatty acids in high-fat diet-induced obese mice. Sci Rep (2015) 0.83

Crystal structure of FAS thioesterase domain with polyunsaturated fatty acyl adduct and inhibition by dihomo-gamma-linolenic acid. Proc Natl Acad Sci U S A (2011) 0.82

Risk of gastric cancer is associated with PRKAA1 gene polymorphisms in Koreans. World J Gastroenterol (2014) 0.82

Chemical inhibition of fatty acid synthase: molecular docking analysis and biochemical validation in ocular cancer cells. J Ocul Biol Dis Infor (2011) 0.82

Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer. J Transl Med (2015) 0.82

Fatty acid synthase inhibitors induce apoptosis in non-tumorigenic melan-a cells associated with inhibition of mitochondrial respiration. PLoS One (2014) 0.81

The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells. J Gastroenterol (2012) 0.81

The pathogenesis of prostate cancer: from molecular to metabolic alterations. Diagn Histopathol (Oxf) (2008) 0.81

Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays. PLoS One (2015) 0.81

FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth. Nat Commun (2016) 0.81

Fatty acid synthase inhibitor C75 ameliorates experimental colitis. Mol Med (2014) 0.81

Comparative Modeling and Molecular Dynamics Simulation of Substrate Binding in Human Fatty Acid Synthase: Enoyl Reductase and β-Ketoacyl Reductase Catalytic Domains. Genomics Inform (2015) 0.80

Maturation and activity of sterol regulatory element binding protein 1 is inhibited by acyl-CoA binding domain containing 3. PLoS One (2012) 0.80

Regulation of peripheral metabolism by substrate partitioning in the brain. Endocrinol Metab Clin North Am (2013) 0.79

Stimulation of carnitine palmitoyltransferase 1 improves renal function and attenuates tissue damage after ischemia/reperfusion. J Surg Res (2012) 0.79

Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis. J Mol Model (2009) 0.78

Substrate recognition by the human fatty-acid synthase. J Biol Chem (2005) 0.78

Fatty acid synthase is a metabolic oncogene targetable in malignant peripheral nerve sheath tumors. Neuro Oncol (2015) 0.77

Differential inhibition of host cell cholesterol de novo biosynthesis and processing abrogates Eimeria bovis intracellular development. Parasitol Res (2014) 0.77

The potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in Tumors. Curr Pharm Biotechnol (2013) 0.77

Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered. J Cell Physiol (2016) 0.77

Evidence of EGR1 as a differentially expressed gene among proliferative skin diseases. Genomic Med (2007) 0.77

Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer. Oncotarget (2016) 0.77

Inhibitory effects of grape skin extract and resveratrol on fatty acid synthase. BMC Complement Altern Med (2013) 0.77

Human UDP-Glucuronosyltransferases: Effects of altered expression in breast and pancreatic cancer cell lines. Cancer Biol Ther (2015) 0.76

The effects of C75, an inhibitor of fatty acid synthase, on sleep and metabolism in mice. PLoS One (2012) 0.75

[6]-Gingerol inhibits de novo fatty acid synthesis and carnitine palmitoyltransferase-1 activity which triggers apoptosis in HepG2. Am J Cancer Res (2015) 0.75

Articles cited by this

A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99

Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry (1989) 3.74

Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci U S A (1994) 3.50

The animal fatty acid synthase: one gene, one polypeptide, seven enzymes. FASEB J (1994) 2.67

Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res (2000) 2.21

Binding site of cerulenin in fatty acid synthetase. J Biochem (1989) 1.98

Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol (1997) 1.93

Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer (1996) 1.92

Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res (1998) 1.83

Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol (1997) 1.76

Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res (1997) 1.70

Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res (1996) 1.69

Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol (1996) 1.68

OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. Urology (1995) 1.56

Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol Chem Hoppe Seyler (1986) 1.45

Purification and crystallization of rat liver fatty acid synthetase. Arch Biochem Biophys (1981) 1.43

Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. Cancer Res (1996) 1.34

Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors. Cancer (1998) 1.18

Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori (1999) 1.17

The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer. J Pathol (1995) 1.16

Biosynthesis of fatty acids by lactating human breast epithelial cells: an evaluation of the contribution to the overall composition of human milk fat. Pediatr Res (1985) 1.13

Fatty acid synthase from rabbit mammary gland. Methods Enzymol (1975) 0.98

Methylenolactocin, a novel antitumor antibiotic from Penicillium sp. J Antibiot (Tokyo) (1988) 0.88

Articles by these authors

Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science (2000) 4.62

Predictive, structure-based model of amino acid recognition by nonribosomal peptide synthetase adenylation domains. Chem Biol (2000) 4.59

Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res (2000) 3.37

Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res (2000) 2.21

Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol (1997) 1.93

A new model for phenotypic suppression of frameshift mutations by mutant tRNAs. Mol Cell (1998) 1.63

Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers. Infect Immun (2001) 1.61

Purification and characterization of clavaminate synthase from Streptomyces clavuligerus: an unusual oxidative enzyme in natural product biosynthesis. Biochemistry (1990) 1.58

Spectroscopic studies of substrate interactions with clavaminate synthase 2, a multifunctional alpha-KG-dependent non-heme iron enzyme: correlation with mechanisms and reactivities. J Am Chem Soc (2001) 1.53

A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol (2000) 1.51

beta-Lactam synthetase: a new biosynthetic enzyme. Proc Natl Acad Sci U S A (1998) 1.39

Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res (2001) 1.38

Two isozymes of clavaminate synthase central to clavulanic acid formation: cloning and sequencing of both genes from Streptomyces clavuligerus. Biochemistry (1992) 1.34

Stereochemistry of methyl group insertion in corrinoid biosynthesis. Determination of carbon isotope chirality by 13C nuclear magnetic resonance. J Am Chem Soc (1973) 1.23

Role of tRNA modification in translational fidelity. Biochim Biophys Acta (1990) 1.21

Demonstration of the catalytic roles and evidence for the physical association of type I fatty acid synthases and a polyketide synthase in the biosynthesis of aflatoxin B1. Chem Biol (1996) 1.19

Structure of beta-lactam synthetase reveals how to synthesize antibiotics instead of asparagine. Nat Struct Biol (2001) 1.15

Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum Pathol (1998) 1.14

Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071). J Med Chem (1999) 1.11

Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients. Cancer Lett (2001) 1.10

Purification, characterization, and cloning of an S-adenosylmethionine-dependent 3-amino-3-carboxypropyltransferase in nocardicin biosynthesis. J Biol Chem (1998) 1.09

Identification, cloning, sequencing, and overexpression of the gene encoding proclavaminate amidino hydrolase and characterization of protein function in clavulanic acid biosynthesis. J Bacteriol (1995) 1.08

Isolation and characterization of the versicolorin B synthase gene from Aspergillus parasiticus. Expansion of the aflatoxin b1 biosynthetic gene cluster. J Biol Chem (1996) 1.06

A new class of antituberculosis agents. J Med Chem (2000) 1.03

Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. J Med Chem (1998) 1.03

Cleavage by calicheamicin gamma 1I of DNA in a nucleosome formed on the 5S RNA gene of Xenopus borealis. Biochemistry (1995) 1.02

Comparison of aspiration vs non-aspiration techniques in fine-needle cytology of thyroid lesions. J Cytol (2010) 1.01

Hexanoate synthase, a specialized type I fatty acid synthase in aflatoxin B1 biosynthesis. Bioorg Chem (2001) 1.00

Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation. Hum Pathol (1998) 1.00

Expansion of the clavulanic acid gene cluster: identification and in vivo functional analysis of three new genes required for biosynthesis of clavulanic acid by Streptomyces clavuligerus. J Bacteriol (2000) 0.99

Kinetic mechanism of the beta-lactam synthetase of Streptomyces clavuligerus. Biochemistry (2000) 0.97

A single monomeric iron center in clavaminate synthase catalyzes three nonsuccessive oxidative transformations. Bioorg Med Chem (1996) 0.96

Requirement of monooxygenase-mediated steps for sterigmatocystin biosynthesis by Aspergillus nidulans. Appl Environ Microbiol (2000) 0.96

Biosynthesis of corrins. I. Experiments with 14-C porphobilinogen and 14-C uroporphyrinogens. J Am Chem Soc (1974) 0.96

Spectrum of renal lesions in HIV patients. J Assoc Physicians India (2000) 0.96

Elucidation of the order of oxidations and identification of an intermediate in the multistep clavaminate synthase reaction. Biochemistry (1991) 0.95

Micro-OSCE for assessment of undergraduates. Indian Pediatr (2004) 0.93

Concerning the biosynthesis of vitamin B12. Trans N Y Acad Sci (1973) 0.93

Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia. Exp Cell Res (2000) 0.92

Expression and purification of two isozymes of clavaminate synthase and initial characterization of the iron binding site. General error analysis in polymerase chain reaction amplification. J Biol Chem (1995) 0.90

Purification and characterization of clavaminate synthase from Streptomyces antibioticus. A multifunctional enzyme of clavam biosynthesis. J Biol Chem (1995) 0.88

Hydroxyl radical footprinting of calicheamicin. Relationship of DNA binding to cleavage. Biochemistry (1994) 0.87

Heterologous expression, isolation, and characterization of versicolorin B synthase from Aspergillus parasiticus. A key enzyme in the aflatoxin B1 biosynthetic pathway. J Biol Chem (1997) 0.86

Purification and characterization of versicolorin B synthase from Aspergillus parasiticus. Catalysis of the stereodifferentiating cyclization in aflatoxin biosynthesis essential to DNA interaction. Biochemistry (1996) 0.86

Role of human chorionic gonadotropin in maintaining 11beta-hydroxysteroid dehydrogenase type 2 expression in human placental syncytiotrophoblasts. Placenta (2009) 0.86

Biosynthesis of corrins. II. Incorporation of 13C-labeled substrates in vitamins B12. J Am Chem Soc (1974) 0.85

Evidence for the colonic origin of ovarian cancer cell line SW626. J Natl Cancer Inst (1999) 0.84

Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. Am J Clin Pathol (2001) 0.84

Pulmonary carcinosarcoma masquerading as a cryptic disseminated malignancy. Indian J Pathol Microbiol (2009) 0.82

Lipogenic enzymes fatty acid synthase and acetyl-coenzyme A carboxylase are coexpressed with sterol regulatory element binding protein and Ki-67 in fetal tissues. Pediatr Dev Pathol (2000) 0.82

Paradoxical stimulation of cyclooxygenase-2 expression by glucocorticoids via a cyclic AMP response element in human amnion fibroblasts. Mol Endocrinol (2009) 0.82

Letter: Concerning the intermediacy of uro'gen III and of a heptacarboxylic uro'gen in corrinoid biosynthesis. J Am Chem Soc (1975) 0.81

A new inducible expression system in a transformed green alga, Chlorella vulgaris. Genet Mol Res (2011) 0.81

Aneurysmal bone cyst of the calcaneum: an expansile locally destructive lesion. J Cancer Res Ther (2011) 0.80

Vascular embolization of benign granulosa cells. Gynecol Oncol (2000) 0.80

Comparison of exercise stress testing with ambulatory electrocardiographic monitoring in the detection of myocardial ischemia after unstable angina pectoris. Am J Cardiol (1991) 0.79

Cross talk between cAMP and p38 MAPK pathways in the induction of leptin by hCG in human placental syncytiotrophoblasts. Reproduction (2011) 0.79

Diagnostic utility of p63 and α-methyl acyl Co A racemase in resolving suspicious foci in prostatic needle biopsy and transurethral resection of prostate specimens. J Cancer Res Ther (2014) 0.79

Biosynthesis of corrinoids. Uroporphyrinogen 3 as a precrusor of vitamin B 12 . J Am Chem Soc (1972) 0.78

A frequent deletion polymorphism on chromosome 22q13 identified by representational difference analysis of ovarian cancer. Genomics (2000) 0.78

Site-directed mutagenesis and biochemical analysis of the endogenous ligands in the ferrous active site of clavaminate synthase. The His-3 variant of the 2-His-1-carboxylate model. Biochemistry (2000) 0.77

Isolation & preliminary characterization of two HIV-2 strains from Pune, India. Indian J Med Res (1999) 0.77

Pure red cell aplasia in systemic onset juvenile idiopathic arthritis. Indian J Hematol Blood Transfus (2011) 0.77

Effect of intravenous infusion on development of pulmonary oedema after inhalation injury. Burns Incl Therm Inj (1983) 0.76

Acute cortical necrosis in Falciparum malaria: an unusual manifestation. Ren Fail (2008) 0.76

High anticancer efficacy of L-proline-m-bis (2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride (MF13) in vivo. Anticancer Res (2001) 0.76

The stereochemical fate of chiral-methyl valines in cephalosporin C biosynthesis. J Nat Prod (1986) 0.75

Hemoptysis in sarcoidosis. Sarcoidosis (1987) 0.75

[Applied anatomy of dorsal nasal fascia for augmentative rhinoplasty]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi (1990) 0.75

Expression of tumor necrosis factor-α and nuclear factor-kappaB/RelA and the pathogenesis of psoriasis. Indian J Pathol Microbiol (2014) 0.75

[Value of evaluating the coronary collateral circulation by transluminal attenuation gradient in patients with chronic total occlusion and related influencing factors]. Zhonghua Xin Xue Guan Bing Za Zhi (2017) 0.75

Migration and leaching risk of extraneous antimony in three representative soils of China: lysimeter and batch experiments. Chemosphere (2013) 0.75

Clonality assessment of lymphoproliferative lesions using the polymerase chain reaction: an analysis of two methods. Indian J Pathol Microbiol (2011) 0.75

[Ectropion of the eyelid due to maxillary osteitis and its treatment (report on 26 cases)]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi (1985) 0.75

[A study of 217 cases of IGA nephropathy]. Zhonghua Nei Ke Za Zhi (1987) 0.75

Successful treatment of dapsone poisoning using commercially available methylene blue crystals. J Indian Med Assoc (1999) 0.75

[Contemporary use of ticagrelor in patients with acute coronary syndrome after discharge]. Zhonghua Yi Xue Za Zhi (2017) 0.75

The temporal bone microdissection of miniature pigs as a useful large animal model for otologic research. Acta Otolaryngol (2013) 0.75

[An analysis of clinical characteristics of twelve cases of mesenteric panniculitis]. Zhonghua Nei Ke Za Zhi (2017) 0.75

Measurement of the degree of coupled isotopic enrichment of different positions in an antibiotic peptide by NMR. J Magn Reson (1997) 0.75

Adsorption voltammetry of the scandium-alizarin red S complex onto a carbon paste electrode. Talanta (2001) 0.75

Is the enemy among us? It's my opinion. Ohio Nurses Rev (1996) 0.75

The diagnosis and surgical treatment of occult otogenic CSF leakage. Acta Otolaryngol (2012) 0.75

Synthesis and reaction of potential alternate substrates and mechanism-based inhibitors of clavaminate synthase. J Nat Prod (1993) 0.75

Biosynthesis of corrinoids. Concerning ithe origin of the methyl groups in vitamin B 12 . J Am Chem Soc (1972) 0.75

A good CV will help your career take off. RN (1992) 0.75

[Immediate reconstruction of soft tissue defects in legs and feet]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi (1985) 0.75

Cardiac function and histological changes after non-dynamic cardiomyoplasty and preliminary study of dynamic cardiomyoplasty. Chin Med J (Engl) (1994) 0.75

[Diagnostic value analysis of capsule endoscopy in obscure gastrointestinal bleeding patients of different ages]. Zhonghua Yi Xue Za Zhi (2017) 0.75